Merck (MRK) EBT Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
156.08% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-56.06% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-37.45% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-159.29% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.63% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
56.46% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
13.82% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
9.05% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-159.29% |
| Dec 31, 2025 |
-17.99% |
| Sep 30, 2025 |
64.91% |
| Jun 30, 2025 |
-16.77% |
| Mar 31, 2025 |
4.11% |
| Dec 31, 2024 |
303.81% |
| Sep 30, 2024 |
-27.22% |
| Jun 30, 2024 |
213.32% |
| Mar 31, 2024 |
55.34% |
| Dec 31, 2023 |
-158.24% |
| Sep 30, 2023 |
56.85% |
| Jun 30, 2023 |
-218.12% |
| Mar 31, 2023 |
-24.91% |
| Dec 31, 2022 |
-10.13% |
| Sep 30, 2022 |
-31.96% |
| Jun 30, 2022 |
161.33% |
| Mar 31, 2022 |
62.74% |
| Dec 31, 2021 |
253.60% |
| Sep 30, 2021 |
94.60% |
| Jun 30, 2021 |
-37.36% |
| Mar 31, 2021 |
-22.17% |
| Dec 31, 2020 |
-69.44% |
| Sep 30, 2020 |
15.30% |
| Jun 30, 2020 |
-15.89% |
| Mar 31, 2020 |
25.14% |
| Dec 31, 2019 |
-157.68% |
| Sep 30, 2019 |
-11.93% |
| Jun 30, 2019 |
56.23% |
| Mar 31, 2019 |
128.03% |
| Dec 31, 2018 |
38.58% |
| Sep 30, 2018 |
1,232.50% |
| Jun 30, 2018 |
-14.47% |
| Mar 31, 2018 |
-32.85% |
| Dec 31, 2017 |
238.57% |
| Sep 30, 2017 |
-93.07% |
| Jun 30, 2017 |
62.17% |
| Mar 31, 2017 |
23.34% |
| Dec 31, 2016 |
-266.18% |
| Sep 30, 2016 |
20.44% |
| Jun 30, 2016 |
86.37% |
| Mar 31, 2016 |
17.60% |
| Dec 31, 2015 |
-93.09% |
| Sep 30, 2015 |
60.87% |
| Jun 30, 2015 |
-57.32% |
| Mar 31, 2015 |
-33.96% |
| Dec 31, 2014 |
864.16% |
| Sep 30, 2014 |
-2.30% |
| Jun 30, 2014 |
51.89% |
| Mar 31, 2014 |
34.90% |
| Dec 31, 2013 |
-8.17% |
| Sep 30, 2013 |
-31.24% |
| Jun 30, 2013 |
-53.54% |
| Mar 31, 2013 |
-38.17% |
| Dec 31, 2012 |
-15.62% |
| Sep 30, 2012 |
-5.70% |
| Jun 30, 2012 |
60.29% |
| Mar 31, 2012 |
45.00% |
| Dec 31, 2011 |
185.23% |
| Sep 30, 2011 |
372.29% |
| Jun 30, 2011 |
34.73% |
| Mar 31, 2011 |
168.06% |
| Dec 31, 2010 |
-114.30% |
| Sep 30, 2010 |
-18.63% |
| Jun 30, 2010 |
60.54% |
| Mar 31, 2010 |
-42.92% |
